Abstract
Assessment of the quality of life (QoL) of human immunodeficiency virus (HIV)-infected subjects is often based on questionnaires in which the items or questions are not seen to be relevant by patients, nor by the users of the data obtained. It therefore seemed appropriate to return to the issue. The methodological and bibliographical research as well as the consultations we conducted convinced us that the elaboration of a new questionnaire was both necessary and possible. In order to do so, we adopted methodological principles based on the Sickness Impact Profile development methodology. First a bibliographical research was conducted in order to study instruments already used for HIV infection. Then, experts concerned with HIV infection and members of patients' associations were interviewed to assess how opportune the development of a new instrument could be. Following this, a methodology was established for the design and construction of the new instrument. One hundred and eighteen candidate questions were generated from an analysis of the content of 20 patients' interviews, which were subsequently submitted to 102 patients, to obtain finally a set of 31 questions from the interpretation of the results obtained from classic psychometric analysis and also from non-classic methods (item response theory and Rasch model). The concept being measured is the impact of illness being experienced by HIV-infected subjects from their own perspective. The range of health states covered by this questionnaire relates to fairly mild conditions. Rasch analysis of this set of 31 questions (HIV-QL31) shows that it corresponds to one unidimensional construct. A single score can be calculated by simple summation of dichotomous response options. This score is highly reliable (Cronbach's α coefficient = 0.93) and is also discriminant regarding the severity of clinical status.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Leplège A, Rude N. The importance of the patients point of view on their own quality of life. AIDS 1995; 9: 1108–1109.
Slevin ML, Plant H, Lynch D et al. Who should measure quality of life, the doctor or the patient? Br J Cancer, 1988; 57: 109–112.
Piettte J, Wachtel TJ, Mor V et al. The impact of age on the quality of life in persons with HIV infection. J Aging Health 1995; 7: 163–178.
Smith M, Minkoff H, Erhlich I, et al. Changes in quality of life of inner city HIV positive women. In Second International Conference on Psychosocial Aspects of HIV infection, Brighton, 1994.
Bindman A, Keanne D, Lurie N. Measuring health changes among severely ill patients: the floor phenomenon. Med Care 1990; 28: 1142–1152.
Wu AW, Rubin HR, Mathews WC et al. A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection. Med Car 1991; 29: 786–798.
Ragsdale D, Morrow JR. Quality of life as a function of HIV classification. Nurs Res 1990; 39, 355–359.
Lübeck DP, Fries JF. Changes in quality of life among persons with HIV infection. Qual Life Res 1992; 1: 359–366.
Lübeck DP, Fries JF. Health status among persons infected with human immunodeficiency virus. A community-based study. Med Care 1993; 31: 269–276.
Bozzette SA, Kanouse DE, Berry S. et al. Health status and function with zidovudine or zalcitabine as initial therapy for AIDS. A randomized controlled trial. Roche 3300/ACTG 114 Study Group. JAMA 1995; 273: 295–301.
Ganz PA, Coscarelli SC, Kahn B et al. Describing the health related quality of life impact of HIV infection: findings from a study using the HIV Overview of Problems-evaluation System (HOPES). Qual Life Res 1993; 2: 109–119.
Barofsky I, Sugarbaker P. Cancer. In: Spilker B, ed. Quality of Life Assessments in Clinical Trials. New York, Raven Press: 1989.
Nunnally JC. Psychometric Theory. New York, McGraw Hill: 1978.
Bergner M, Bobbitt R, Pollard W et al. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1976; 19: 787–805.
Bergner M. Quality of life, health status and clinical research. Med Care 1989; 27: S148–S156.
Bergner M et al. The Sickness Impact Profile: validation of a health status measure. Med Care 1976; 14: 57–67.
Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36). Conceptual framework and item selection. Med Care 1992; 30: 473–483.
Leplège A. Mesbah M, Marquis P. Analyse préliminaire des propriétés psychométriques de la version française d;un questionnaire international de mesure de qualité de vie: le MOS SF-36 (version 1.1). Rev Epidem Sante Pub 1995; 43: 371–379.
Leplège A, Mesbah M, Ecosse E, Verdier A. Translation, cultural adaption and prelimminary psychometric evaluation of the French version of the SF-36. J Clin Epidemial 1997; in press.
Butters E, Higginson I, George R et al. Assessing the symptoms, anxiety and practical needs of HIV/AIDS patients receiving palliative care. Qual Life Res 1992; 1: 47–51.
Wu AW, Mathews WC, Brysk LT et al. Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS related complex. J AIDS 1990; 3: 683–690.
Gelber RD, Lenderking WR, Cotton DJ et al. Quality of life evaluation in a clinical trial of zidovudine therapy in patients with mildly symptomatic HIV infection. The AIDS Clinical Trials Group. Ann Intern Med 1992; 116: 961–966.
Wright BD, Stone MH. In: Best Test Design, Rasch Measurement. Chicago: MESA Press.
Wright BD, Masters GN. In: Rating Scale Analysis, Rasch Measurement. Chicago: MESA Press.
Leplège A, Hunt S. The problem of quality of life in medicine. JAMA 1997.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Leplège, A., Rude, N., Ecosse, E. et al. Measuring quality of life from the point of view of HIV-positive subjects: the HIV-QL31. Qual Life Res 6, 585–594 (1997). https://doi.org/10.1023/A:1018468301617
Issue Date:
DOI: https://doi.org/10.1023/A:1018468301617